A phase 2 study of Vactosertib combination with Onivide for treatment of Pancreatic cancer
Latest Information Update: 16 May 2023
At a glance
- Drugs Vactosertib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
Most Recent Events
- 16 May 2023 New trial record
- 28 Apr 2023 According to a Medpacto media release, the company is also preparing for a global phase 2 IND application.